PHIO PHARMACEUTICALS CORP. Cash
PHIO PHARMACEUTICALS CORP. (PHIO) had Cash of $6.47 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2024-05-09
- 2024-03-31: Cash $6.47M.
- 2023-12-31: Cash $8.49M.
- 2023-09-30: Cash $8.41M.
- 2023-06-30: Cash $11.31M.
| Period end | Cash |
|---|---|
| 2024-03-31 | $6.47M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $8.49M 10-K · filed 2024-04-01 |
| 2023-09-30 | $8.41M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.31M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $9.04M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $11.78M 10-K · filed 2024-04-01 |
| 2022-09-30 | $14.48M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $18.02M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $20.46M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $24.06M 10-K · filed 2023-03-22 |
| 2021-09-30 | $26.53M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $29.43M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $32.70M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $14.24M 10-K · filed 2022-03-22 |
| 2020-09-30 | $16.87M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $18.86M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $13.28M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $6.93M 10-K · filed 2021-03-25 |
| 2019-09-30 | $8.71M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.82M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $12.75M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $14.88M 10-K · filed 2020-03-26 |
| 2017-12-31 | $3.58M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |